Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.445 USD | +4.04% | +0.41% | -51.40% |
Mar. 15 | AC Immune Files $350 Million Mixed Shelf | MT |
Mar. 14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.40% | 221M | |
+2.67% | 42.75B | |
+47.70% | 41.61B | |
+12.26% | 41.34B | |
-8.83% | 26.59B | |
+8.39% | 25.49B | |
-22.52% | 18.12B | |
+31.20% | 12.24B | |
-1.48% | 11.76B | |
+9.05% | 11B |
- Stock Market
- Equities
- ACIU Stock
- News AC Immune SA
- AC Immune to Regain Global Rights of Crenezumab, Semorinema